trophy-u-01 cohort 3: sacituzumab govitecan pembrolizumab for patients with muc
Published 2 years ago • 110 plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
4:25
trophy-u-01: sacituzumab govitecan in patients with muc after failure of platinum-based regimens...
-
2:16
efficacy of sacituzumab govitecan by trop-2 expression in patients with muc
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
5:01
sacituzumab govitecan in patients with previously treated muc
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
2:20
ev-103 cohort k: enfortumab vedotin /- pembro in untreated cis-ineligible patients with muc
-
2:06:04
uromet 3.1
-
3:55
oncopower trodelvy (sacituzumab govitecan-hziy) and what are its side effects? | oncopower
-
5:00
journey of strength, courage and faith - wilms tumor
-
3:39
sacituzumab govitecan in previously treated metastatic urothelial carcinoma
-
1:02
operations for solid tumors
-
7:26
the sthlm3mri trial
-
1:30
potential of platinum-free treatment approaches in patients with muc
-
6:01
sacituzumab govitecan given accelerated fda approval for advanced urothelial cancer
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
2:30
final os results of imvigor130: atezolizumab plus platinum/gemcitabine for muc
-
1:40
safety results from phase 3b strong trial of durvalumab in patients with urinary tract carcinoma
-
2:12
treatment sequencing in patients with muc who have relapsed on ici
-
0:24
wilms tumor - long term outcomes
-
5:27
sacituzumab govitecan demonstrates metastatic urothelial cancer benefit | yohann loriot
-
0:44
operation for wilms tumor
-
4:04
efficacy of sacituzumab govitecan by trop-2 expression in metastatic urothelial carcinoma